$CRSP SEC Filings

Filed On	Filing
21 Oct 2026	Form 4: Silver Andrew Jacob, Chief Financial Officer Granted 25,000 Restricted Stock Units
21 Oct 2026	Form 3: Silver Andrew Jacob, Chief Financial Officer
20 Oct 2026	Form 4: Kulkarni Samarth, Director Received 100,000 shares by exercise or conversion · Sold 47,837 shares ($2.38M)
19 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers This Employment Agreement (“Agreement”) is made as of the Nineteenth (19th) day of October, 2026 between CRISPR Therapeutics, Inc., a Delaware corporation (the “Company”), and Andrew J. Silver (the “Executive” and, together with the Comp...
16 Oct 2026	Form 4: George Simeon, Director Received 30,000 shares by exercise or conversion ($420K) · Sold 14,514 shares ($720K)
15 Oct 2026	Form 4: Kasinger James R., General Counsel and Secretary Received 2,113 shares by exercise or conversion · Sold 1,040 shares ($51.2K)
15 Oct 2026	Form 4: Kulkarni Samarth, Director Received 8,333 shares by exercise or conversion · Sold 4,098 shares ($202K)
14 Oct 2026	144
08 Oct 2026	Form 4: Kasinger James R., General Counsel and Secretary Received 1,990 shares by exercise or conversion ($27.1K) · Sold 1,990 shares ($119K)
06 Oct 2026	144
24 Sep 2026	Form 4: Kasinger James R., General Counsel and Secretary Received 10,400 shares by exercise or conversion ($142K) · Sold 10,400 shares ($626K)
22 Sep 2026	144
21 Sep 2026	Form 4: Behbahani Ali, Director Received 30,000 shares by exercise or conversion ($420K) · Sold 13,679 shares ($781K)
21 Sep 2026	Form 4: Behbahani Ali, Director Acquired 75 shares (Other Transaction)
17 Sep 2026	144
14 Aug 2026	SCHEDULE 13G/A
11 Aug 2026	Form 4: Prasad Raju, Chief Financial Officer Gave 750 shares as a gift
03 Aug 2026	10-Q
03 Aug 2026	8-K: Results of Operations and Financial Condition
27 Jul 2026	SCHEDULE 13G/A

Comments